They like to talk about earnings weeks before the actual filing to sell some shares. Last time they gave an actual EBITDA number of approximately $163K. You can see from the segmented earnings table that they were off juussst a bit. This time they threw a percentage out there along with a disclaimer and traders weren't buying it. LOL a disclaimer this time! Traders bought up a bunch of those shares but not at the level they chased it last time and they didn't raise much money today. Rather, like I have been saying, they probably raised more off the tweet tease. Those who have bought on the day of a press release have become bag holders and today, though down 25%, will likely not be an exception.
The segmented information for the ARIA treatment center will show an EBITDA of approximately $163,000 for the fourth quarter which was an approximately 370% increase over the third quarter of 2021.
Ethema Posts Strong Revenue Guidance for Second Quarter June 30, 2022 12:07 ET | Source: Ethema Health Corporation
...expects its ARIA subsidiary to report a revenue increase of 13% for the second quarter 2022 over the first quarter 2022...
..This expectation is an estimate based on claims submissions to date and the historical collections percentage averages experienced in recent history...
News 
Market Data 
Discover 
